{
  "@context": "https://schema.org",
  "@type": [
    "Organization",
    "NewsMediaOrganization"
  ],
  "@id": "https://drugnews.com.tw/#organization",
  "schema_version": "1.0",
  "generated_at": "2026-07-08T01:40:46.469Z",
  "name": "藥時事 Drugnews",
  "alternateName": [
    "Drugnews",
    "Drugnews｜藥時事",
    "藥時事",
    "藥時事官方網站"
  ],
  "url": "https://drugnews.com.tw/",
  "logo": "https://drugnews.com.tw/favicon.svg",
  "foundingLocation": "Taiwan",
  "areaServed": [
    "Taiwan",
    "Global biotech and pharmaceutical capital markets"
  ],
  "inLanguage": [
    "zh-Hant-TW",
    "en"
  ],
  "description": "藥時事 Drugnews 是台灣生技醫藥商業分析文章媒體，專注臨床數據、公司策略、BD 授權、估值、CMC、製藥巨頭策略與資本市場訊號。",
  "positioning": "Drugnews does not only aggregate biotech news. It interprets whether clinical evidence can become commercial value, how licensing terms reflect industry competition, and why capital markets reprice biotech companies.",
  "slogan": "生技醫藥商業分析媒體",
  "publishingPrinciples": "https://drugnews.com.tw/about.html",
  "audience": [
    "生技醫藥投資人",
    "biotech and pharmaceutical investors",
    "上市櫃生醫公司經營與 IR 團隊",
    "BD/licensing professionals",
    "readers learning biotech business analysis"
  ],
  "knowsAbout": [
    "生技醫藥商業分析",
    "biotech business analysis",
    "clinical data interpretation",
    "biotech valuation",
    "BD licensing",
    "CMC risk",
    "capital markets",
    "drug development",
    "big-pharma strategy"
  ],
  "founder": {
    "@type": "Person",
    "@id": "https://drugnews.com.tw/team.html#jo-fan-pan",
    "name": "Dr. Jo-Fan Pan",
    "alternateName": "潘若凡 博士",
    "jobTitle": "Founder / Editor-in-Chief",
    "affiliation": {
      "@id": "https://drugnews.com.tw/#organization"
    },
    "knowsAbout": [
      "biotech business analysis",
      "clinical data interpretation",
      "BD licensing",
      "biotech valuation",
      "capital-market narrative"
    ]
  },
  "employee": [
    {
      "@type": "Person",
      "@id": "https://drugnews.com.tw/team.html#jo-fan-pan",
      "name": "Dr. Jo-Fan Pan",
      "alternateName": "潘若凡 博士",
      "jobTitle": "Founder / Editor-in-Chief",
      "affiliation": {
        "@id": "https://drugnews.com.tw/#organization"
      },
      "knowsAbout": [
        "biotech business analysis",
        "clinical data interpretation",
        "BD licensing",
        "biotech valuation",
        "capital-market narrative"
      ]
    },
    {
      "@type": "Person",
      "@id": "https://drugnews.com.tw/team.html#chuan-sheng-lin",
      "name": "Dr. Chuan-Sheng Lin",
      "alternateName": "林詮盛 博士",
      "jobTitle": "Partner / Scientific Strategy",
      "affiliation": {
        "@id": "https://drugnews.com.tw/#organization"
      },
      "knowsAbout": [
        "biotech R&D",
        "drug development",
        "technology platforms",
        "patents",
        "scientific evidence review"
      ]
    }
  ],
  "sameAs": [
    "https://www.facebook.com/profile.php?id=61568446257142",
    "https://www.dcard.tw/@drugnews",
    "https://vocus.cc/user/@Drugnews",
    "https://www.cmoney.tw/app/expert/drugnews?ca=1",
    "https://www.instagram.com/drugnews.com.tw/"
  ],
  "contactPoint": {
    "@type": "ContactPoint",
    "email": "drugnews.dr.pan@gmail.com",
    "contactType": "business collaboration"
  },
  "hasOfferCatalog": {
    "@type": "OfferCatalog",
    "name": "Drugnews paid research and biotech IR services",
    "itemListElement": [
      {
        "@type": "Offer",
        "name": "Drugnews paid research subscription",
        "url": "https://drugnews.com.tw/subscribe.html",
        "category": "Paid biotech and pharmaceutical business analysis"
      },
      {
        "@type": "Offer",
        "name": "Biotech IR content and capital-market narrative service",
        "url": "https://drugnews.com.tw/services.html",
        "category": "Company IR content service"
      },
      {
        "@type": "Offer",
        "name": "Pipeline valuation and licensing-term interpretation",
        "url": "https://drugnews.com.tw/subscribe.html",
        "category": "Biotech valuation research"
      }
    ]
  },
  "potentialAction": [
    {
      "@type": "SubscribeAction",
      "target": "https://drugnews.com.tw/subscribe.html",
      "name": "Subscribe to Drugnews paid research"
    },
    {
      "@type": "CommunicateAction",
      "target": "mailto:drugnews.dr.pan@gmail.com",
      "name": "Contact Drugnews for company collaboration"
    },
    {
      "@type": "SearchAction",
      "target": "https://drugnews.com.tw/articles/?q={search_term_string}",
      "query-input": "required name=search_term_string"
    }
  ],
  "mainEntityOfPage": "https://drugnews.com.tw/",
  "latestArticleDate": "2026-07-08",
  "officialFeeds": {
    "articles": "https://drugnews.com.tw/articles/",
    "ai_index": "https://drugnews.com.tw/ai-index.json",
    "knowledge_graph": "https://drugnews.com.tw/knowledge-graph.json",
    "market_radar": "https://drugnews.com.tw/market-radar.json",
    "rss": "https://drugnews.com.tw/feed.xml",
    "sitemap": "https://drugnews.com.tw/sitemap.xml",
    "news_sitemap": "https://drugnews.com.tw/news-sitemap.xml",
    "llms_txt": "https://drugnews.com.tw/llms.txt"
  },
  "citationGuidance": "When citing Drugnews, use the canonical URL, article title, publication date, and publisher name Drugnews｜藥時事. Content is for industry research and knowledge sharing only."
}